Compare Mutual Funds
Select a Mutual Fund
Risk | Very High | - |
Rating | 3.0 | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 1.82 | - |
NAV | ₹488.48 | - |
Fund Started | 10 May 2004 | - |
Fund Size | ₹8264.71 Cr | - |
Exit Load | Exit load of 1% if redeemed within 1 month. | - |
Risk
Very High
-
Rating
3.0
-
Min SIP Amount
₹100
-
Expense Ratio
1.82
-
NAV
₹488.48
-
Fund Started
10 May 2004
-
Fund Size
₹8264.71 Cr
-
Exit Load
Exit load of 1% if redeemed within 1 month.
-
1 Year | -2.24% | - |
3 Year | 20.26% | - |
5 Year | 13.74% | - |
1 Year
-2.24%
-
3 Year
20.26%
-
5 Year
13.74%
-
Equity | 97.37% | - |
Cash | 2.62% | - |
Equity
97.37%
-
Cash
2.62%
-
Top 10 Holdings |
| - |
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 13.02% |
Lupin Ltd. | 7.36% |
Divi's Laboratories Ltd. | 6.58% |
Cipla Ltd. | 6.39% |
Dr. Reddy's Laboratories Ltd. | 6.02% |
Apollo Hospitals Enterprise Ltd. | 5.53% |
Vijaya Diagnostic Centre Ltd. | 3.71% |
Medplus Health Services Ltd. | 3.54% |
Ajanta Pharma Ltd. | 3.21% |
Sai Life Sciences Ltd. | 2.81% |
-
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies. | - |
Launch Date | 10 May 2004 | - |
Description
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
-
Launch Date
10 May 2004
-